Symbiosis Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 29-06-2024
- Paid Up Capital ₹ 0.50 M
as on 29-06-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2014
About Symbiosis Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anubhav Chavan, Rajesh Bhalotia, Vishwambhar Gupta, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85100CH2009PLC031850
- Company No.
031850
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2009
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Symbiosis Life Sciences?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagbir Singh  | Director | Current | |
| Anubhav Chavan | Additional Director | 07-Jan-2010 | Current |
| Rajesh Bhalotia | Director | Current | |
| Vishwambhar Gupta | Director | Current | |
| Rajnish Kumar | Director | 05-Nov-2009 | Current |
| Sham Lal | Director | Current |
Financial Performance and Corporate Structure Insights of Symbiosis Life Sciences.
Enhance accessibility to Symbiosis Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Symbiosis Life Sciences?
Unlock access to Symbiosis Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Symbiosis Pharmaceuticals Private Limited
Active
21 years 6 months Vishwambhar Gupta and Jagbir Singh are mutual person
Wonder Chemicals And Coatings Limited
Active 14 years 4 months Rajesh Bhalotia and Sunanda Bhalotia are mutual person
Interglobe Wonder Products Private Limited
Active 3 years 11 months Rajesh Bhalotia and Sunanda Bhalotia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Symbiosis Life Sciences?
Unlock and access historical data on people associated with Symbiosis Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbiosis Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
